We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$567M
AUM Growth
+$36.3M
Cap. Flow
-$1.21M
Cap. Flow %
-0.21%
Top 10 Hldgs %
39.98%
Holding
84
New
4
Increased
23
Reduced
43
Closed
1

Top Buys

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$6.84M
2
CPHD
Cepheid Inc
CPHD
+$5.49M
3
INGN icon
Inogen
INGN
+$1.53M
4
WSM icon
Williams-Sonoma
WSM
+$942K
5
HPE icon
Hewlett Packard
HPE
+$467K

Top Sells

Rank Stock Value
1
SSYS icon
Stratasys
SSYS
+$4.64M
2
BIIB icon
Biogen
BIIB
+$2M
3
TRMB icon
Trimble
TRMB
+$1.84M
4
BF.B icon
Brown-Forman Class B
BF.B
+$936K
5
OXY icon
Occidental Petroleum
OXY
+$823K

Sector Composition

Rank Sector Weight
1 Healthcare 41.06%
2 Industrials 11.92%
3 Technology 10.32%
4 Consumer Staples 9.08%
5 Energy 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBA
76
DELISTED
Walgreens Boots Alliance
WBA
$230K 0.04%
2,700
AAPL icon
77
Apple
AAPL
$4.97T
$213K 0.04%
8,108
SHPG
78
DELISTED
Shire pic
SHPG
$205K 0.04%
1,000
NKTR icon
79
Nektar Therapeutics
NKTR
$2.39B
-3,340
Closed -$549K

Similar funds

Tirschwell & Loewy's Q4 2015 Portfolio in Review

As of Q4 2015, Tirschwell & Loewy held 84 positions worth $567M, up 6.8% from $531M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tirschwell & Loewy's Q4 2015 filing shows 4 new, 23 increased, 43 reduced and 1 closed positions. Its largest new stake was Abiomed Inc: 80,615 shares worth $7.28M. The largest sale was Stratasys, an estimated $4.64M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Industrials and Technology.

  • Tirschwell & Loewy's largest Q4 2015 buy was Abiomed Inc: 80,615 shares worth $7.28M.
  • Tirschwell & Loewy added most to Cepheid Inc in Q4 2015, an estimated $5.49M increase.
  • Tirschwell & Loewy's biggest Q4 2015 reduction was Stratasys, cutting an estimated $4.64M.
  • Tirschwell & Loewy fully exited Nektar Therapeutics in Q4 2015, selling an estimated $549K.
  • Tirschwell & Loewy's ten largest holdings make up 40% of its $567M portfolio in Q4 2015.
  • Tirschwell & Loewy opened 4 new positions and closed 1 in Q4 2015.
  • Tirschwell & Loewy's portfolio value rose 6.8% quarter-over-quarter to $567M.

Based on Tirschwell & Loewy's 13F filing for Q4 2015, filed 7 Jan 2016.